T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLSA
1451
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $7.27M | ﹤0.01% |
737,370
| – | – |
|
1452
Aramark
ARMK
$16.1B
| $7.21M | ﹤0.01% |
271,150
-1,475
| -0.5% | -$38.6K |
|
1453
OSI Systems
OSIS
$3.82B
| $7.16M | ﹤0.01% |
76,819
-161,459
| -68% | -$15.1M |
|
1454
HEICO Corp Class A
HEI.A
$38B
| $7.01M | ﹤0.01% |
54,512
+1,687
| +3% | +$215K |
|
1455
OGE Energy
OGE
$9.69B
| $6.83M | ﹤0.01% |
178,097
+2,703
| +2% | +$94.7K |
|
1456
InnovAge Holding
INNV
$1.42B
| $6.82M | ﹤0.01% |
1,363,257
+879,478
| +182% | +$6.39M |
|
1457
Cytokinetics
CYTK
$10.2B
| $6.81M | ﹤0.01% |
149,439
+119,982
| +407% | +$4.63M |
|
1458
Sunrun
RUN
$2.37B
| $6.78M | ﹤0.01% |
197,732
+100,023
| +102% | +$4.68M |
|
1459
AMC Entertainment Holdings
AMC
$2.35B
| $6.72M | ﹤0.01% |
24,710
+467
| +2% | +$164K |
|
1460
EPR Properties
EPR
$4.7B
| $6.7M | ﹤0.01% |
141,020
+17,033
| +14% | +$845K |
|
1461
Crown Holdings
CCK
$13.1B
| $6.65M | ﹤0.01% |
60,117
-3,829
| -6% | -$407K |
|
1462
Dell
DELL
$320B
| $6.61M | ﹤0.01% |
117,754
-118,538
| -50% | -$6.61M |
|
1463
Carlisle Companies
CSL
$15.2B
| $6.6M | ﹤0.01% |
26,610
-794
| -3% | -$182K |
|
1464
Lyft
LYFT
$6.48B
| $6.54M | ﹤0.01% |
153,174
-20,270
| -12% | -$948K |
|
|
ONEM
1465
DELISTED
1Life Healthcare
ONEM
| $6.52M | ﹤0.01% |
370,911
+265,233
| +251% | +$5.14M |
|
1466
Liberty Global Class C
LBTYK
$3.46B
| $6.38M | ﹤0.01% |
226,981
+17,881
| +9% | +$510K |
|
|
OLO
1467
DELISTED
Olo Inc
OLO
| $6.03M | ﹤0.01% |
289,863
+48,360
| +20% | +$1.26M |
|
1468
Royal Bank of Canada
RY
$297B
| $5.96M | ﹤0.01% |
56,129
+2,699
| +5% | +$280K |
|
|
ELAT
1469
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $5.96M | ﹤0.01% |
133,923
+5,871
| +5% | +$282K |
|
1470
Virgin Galactic
SPCE
$475M
| $5.89M | ﹤0.01% |
21,996
+17,551
| +395% | +$6.34M |
|
1471
Ryder
R
$10.1B
| $5.85M | ﹤0.01% |
71,010
-154,345
| -68% | -$12.9M |
|
1472
Zillow
Z
$8.08B
| $5.82M | ﹤0.01% |
91,097
+3,512
| +4% | +$253K |
|
1473
loanDepot
LDI
$320M
| $5.75M | ﹤0.01% |
+1,198,064
| New | +$7.02M |
|
1474
Wyndham Hotels & Resorts
WH
$5.49B
| $5.73M | ﹤0.01% |
63,877
-3,408
| -5% | -$285K |
|
1475
MaxCyte
MXCT
$149M
| $5.67M | ﹤0.01% |
556,816
+55,494
| +11% | +$596K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.